[HTML][HTML] 探索性应用抗PD-1 抗体治疗晚期胰腺癌的观察研究
张紫腾， 宋文广 - Advances in Clinical Medicine, 2021 - hanspub.org
… and efficacy of anti-PD-1 antibody in the treatment of 18 patients … , 18 patients with advanced
pancreatic cancer who failed first-… combined with chemotherapy were leukopenia (44.4%), …
pancreatic cancer who failed first-… combined with chemotherapy were leukopenia (44.4%), …
基于免疫检查点PD-1 的肿瘤免疫耐药机制及耐药后再治疗的策略
黎钰欣， 金风 - 肿瘤防治研究, 2022 - zlfzyj.com
… as the fourth cancer treatment after surgery, radiotherapy and chemotherapy. With the in-…
A combination of PD-1/PD-L1 inhibitors: The prospect of overcoming the weakness of tumor …
A combination of PD-1/PD-L1 inhibitors: The prospect of overcoming the weakness of tumor …
晚期食管癌PD-1/PD-L1 免疫检查点抑制剂疗法的Cochrane Meta 分析.
许雨柔， 邹宜丰， 蔡宁， 范佳慧… - … University Journal of …, 2023 - search.ebscohost.com
… ,radiotherapy or chemotherapy,and to compare the efficacy of different treatment strategies.
… of PD-1/PD-L1 inhibitor and/or combined operation,radiotherapy and chemotherapy can …
… of PD-1/PD-L1 inhibitor and/or combined operation,radiotherapy and chemotherapy can …
PD-1/PD-L1 抑制剂联合抗血管生成药物治疗晚期三阴性乳腺癌的研究进展
黄世芬， 令晓玲 - 肿瘤防治研究, 2021 - zlfzyj.com
… versus single-agent chemotherapy (chemo) for metastatic … Efficacy of apatinib combined
with GP regimen in the treatment of advanced recurrent triple negative breast cancer after failure …
with GP regimen in the treatment of advanced recurrent triple negative breast cancer after failure …
[HTML][HTML] 放疗联合免疫检查点抑制剂治疗非小细胞肺癌介入时机及安全性的研究进展
李雪娜， 赵红 - Advances in Clinical Medicine, 2024 - hanspub.org
… However, the efficacy of ICIs alone in the treatment of … the mechanism of the combined
radiotherapy and ICIs therapy, … 基于RT触发的抗原爆发微环境,通过抗PD 1/PD-L1抗体的共同刺激,…
radiotherapy and ICIs therapy, … 基于RT触发的抗原爆发微环境,通过抗PD 1/PD-L1抗体的共同刺激,…
[HTML][HTML] EGFR 突变的晚期非小细胞肺癌的抗PD-1/PD-L1 治疗研究进展
朱悦， 戴朝霞 - Chinese Journal of Lung Cancer, 2022 - ncbi.nlm.nih.gov
… 1-2 years, and the following treatment efficacy is poor. The invention of programmed cell death
… Clinical trials of chemotherapy combined with anti-PD-1/PD-L1 after EGFR-TKI resistance …
… Clinical trials of chemotherapy combined with anti-PD-1/PD-L1 after EGFR-TKI resistance …
[PDF][PDF] 抗PD-1/PD-L1 抗体药物的全球市场规模影响因素分析及市场预测
周峰， 吴骋 - Chinese Journal of New Drugs, 2018 - xqdoc.imedao.com
… Previous radiotherapy and the clinical activity and toxicity of pem… Efficacy and safety of
durvalumab in locally advanced or … lymphoma after brentuximab vedotin failure[J]. J Clin Oncol,…
durvalumab in locally advanced or … lymphoma after brentuximab vedotin failure[J]. J Clin Oncol,…
PD-1/PD-L1 抑制剂在结外NK/T 细胞淋巴瘤中的应用现状
刘悦， 亓姝楠， 李晔雄 - 中国癌症防治杂志, 2024 - zgazfz.com
… /2信号通路上 调肿瘤细胞中的PD⁃L1表达[21].此外,有小样本研究 提示,ENKTCL患者的效应T细胞
上的PD⁃1表达水平 也高于健康对照组人群[22]… Prediction of immunotherapy efficacy based …
上的PD⁃1表达水平 也高于健康对照组人群[22]… Prediction of immunotherapy efficacy based …
免疫治疗时代背景下放疗在晚期食管癌中的应用进展
王澜 - 肿瘤防治研究, 2024 - zlfzyj.com
… Combining systemic treatment with local treatment and seeking new comprehensive … for
improving efficacy. This article reviews the research progress and prospects of radiotherapy in …
improving efficacy. This article reviews the research progress and prospects of radiotherapy in …
局部晚期头颈鳞状细胞癌诱导免疫治疗联合化疗探索研究
刘海英， 赵广章， 崔巍， 谷振芳， 胡东玉， 赵静 - 中国耳鼻咽喉头颈外科, 2023 - entbjb.com
… The other 9 patients failed to perform CPS assay and PD-L1 … followed by cisplatin or
cetuximab concomitant to radiotherapy for … Anti-PD-1 and AntiPD-L1 in head and neck cancer: a …
cetuximab concomitant to radiotherapy for … Anti-PD-1 and AntiPD-L1 in head and neck cancer: a …